AI ASSISTANT
Ask DrugCentral
Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
alfaxalone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 133 | 23930-19-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 2.03 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2B,AXL,BRAF,BTK,CAMK2D,CDK5,CDK9,EIF2AK3,EPHB4,ERBB2,GRK2,ITK,MAPK10,MAPK7,NTRK2,PDK1,PDK2,PDK4,PRKDC,TEK,TGFBR1 | 21 | |||
| kinase-selectivity-class | EIF2AK3 | 1 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 1, 1972 | YEAR INTRODUCED |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | N01AX05 | NERVOUS SYSTEM ANESTHETICS ANESTHETICS, GENERAL Other general anesthetics |
| MeSH PA | D000081227 | Neurosteroids |
| MeSH PA | D000777 | Anesthetics |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D002492 | Central Nervous System Depressants |
| MeSH PA | D018377 | Neurotransmitter Agents |
Related Drugs by ATC class:
N01AX Other general anesthetics 8 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cats | Induction and maintenance of general anesthesia | Indication |
| Cats | Anesthesia followed by maintenance with an inhalant anesthetic | Indication |
| Dogs | Induction and maintenance of general anesthesia | Indication |
| Dogs | Anesthesia followed by maintenance with an inhalant anesthetic | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Alfaxan Multidose | Jurox Pty. Ltd. | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Sodium- and chloride-dependent GABA transporter 1 | Transporter | WOMBAT-PK | |||||||
| GABA-A receptor alpha-1/beta-2/gamma-2 | Ion channel | EC50 | 5.70 | WOMBAT-PK | |||||
| GABA A receptor alpha-2/beta-2/gamma-2 | Ion channel | EC50 | 5.70 | CHEMBL | |||||
| GABA-A receptor; anion channel | Ion channel | IC50 | 6.52 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| D07282 | KEGG_DRUG |
| 1544577 | RXNORM |
| C0051482 | UMLSCUI |
| CHEBI:34531 | CHEBI |
| EY4 | PDB_CHEM_ID |
| CHEMBL190279 | ChEMBL_ID |
| DB11371 | DRUGBANK_ID |
| C006477 | MESH_SUPPLEMENTAL_RECORD_UI |
| 3218 | INN_ID |
| BD07M97B2A | UNII |
| 104845 | PUBCHEM_CID |
| 5461 | IUPHAR_LIGAND_ID |
| 116553001 | SNOMEDCT_US |
| 387037009 | SNOMEDCT_US |
| BD07M97B2A | INXIGHT DRUGS |
Pharmaceutical products:
None